Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by low platelet counts and variable bleeding risk. In children, the disease often resolves spontaneously within a year, but approximately 30% progress to chronic ITP, which poses long-term management challenges. Current predictors for disease chronicity are limited, creating uncertainty in early clinical decision-making.
Study Design: Building a Predictive Tool
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
